NSE › Healthcare

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

—

Latest quarter · ended 2026-03-31

Revenue
₹904 cr
Revenue YoY
+1.2%
Net profit
₹101 cr
Profit YoY
-30.4%
EPS
₹7.60
EPS estimate
₹8.40
Net margin
11.2%

EPS came in at 7.60 against a street estimate of 8.40 — a miss of 9.5%.

Key statistics

Market cap
₹38,793 cr
P/E
54.2
Forward P/E
40.5
P/B
9.30
Book value
₹259.05
EPS (TTM)
₹44.56
Dividend yield
0.91%
52-week high
₹2,525.50
52-week low
₹1,620.66
50-day MA
₹2,271.08
200-day MA
₹2,003.10
Beta
-0.02

Analyst view

with an average price target of ₹2,307.12.

Shareholding

Promoters
49.23%
Institutions
30.78%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for JB Chemicals & Pharmaceuticals Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.